KRTX Annual SG&A
$131.33 M
+$55.26 M+72.65%
31 December 2023
Summary:
As of February 2, 2025, KRTX annual selling, general & administrative expenses is $131.33 million, with the most recent change of +$55.26 million (+72.65%) on December 31, 2023. During the last 3 years, it has risen by +$102.92 million (+362.30%).KRTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRTX Quarterly SG&A
$47.39 M
+$15.13 M+46.89%
31 December 2023
Summary:
As of February 2, 2025, KRTX quarterly selling, general & administrative expenses is $47.39 million, with the most recent change of +$15.13 million (+46.89%) on December 31, 2023. Over the past year, it has increased by +$15.13 million (+46.89%).KRTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRTX TTM SG&A
-$3.31 B
-$433.68 M-15.08%
31 December 2023
Summary:
As of February 2, 2025, KRTX TTM selling, general & administrative expenses is -$3.31 billion, with the most recent change of -$433.68 million (-15.08%) on December 31, 2023. Over the past year, it has dropped by -$3.42 billion (-3156.63%).KRTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +72.7% | +46.9% | -3156.6% |
| 3 y3 years | +362.3% | +46.9% | -3156.6% |
| 5 y5 years | +4315.9% | +46.9% | -3156.6% |
KRTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | at high | -2619.4% |
Karuna Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $131.33 M(+72.7%) | $47.39 M(+46.9%) | $131.33 M(+21.3%) |
| Sept 2023 | - | $32.27 M(+17.7%) | $108.25 M(+13.8%) |
| June 2023 | - | $27.42 M(+13.0%) | $95.11 M(+11.2%) |
| Mar 2023 | - | $24.25 M(-0.2%) | $85.53 M(+12.4%) |
| Dec 2022 | $76.07 M(+44.6%) | $24.31 M(+27.1%) | $76.07 M(+5.9%) |
| Sept 2022 | - | $19.13 M(+7.2%) | $71.82 M(+10.3%) |
| June 2022 | - | $17.84 M(+20.7%) | $65.09 M(+12.9%) |
| Mar 2022 | - | $14.79 M(-26.3%) | $57.63 M(+9.5%) |
| Dec 2021 | $52.62 M(+85.2%) | $20.06 M(+61.9%) | $52.62 M(+27.2%) |
| Sept 2021 | - | $12.39 M(+19.3%) | $41.38 M(+15.2%) |
| June 2021 | - | $10.38 M(+6.2%) | $35.93 M(+10.4%) |
| Mar 2021 | - | $9.78 M(+10.8%) | $32.55 M(+14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $28.41 M(+36.1%) | $8.82 M(+27.1%) | $28.41 M(+21.1%) |
| Sept 2020 | - | $6.94 M(-0.9%) | $23.46 M(+13.8%) |
| June 2020 | - | $7.01 M(+24.3%) | $20.62 M(-5.8%) |
| Mar 2020 | - | $5.63 M(+45.5%) | $21.90 M(+4.9%) |
| Dec 2019 | $20.87 M(+601.7%) | $3.87 M(-5.6%) | $20.87 M(+13.3%) |
| Sept 2019 | - | $4.10 M(-50.5%) | $18.42 M(+19.8%) |
| June 2019 | - | $8.29 M(+79.9%) | $15.37 M(+109.3%) |
| Mar 2019 | - | $4.61 M(+223.0%) | $7.34 M(+146.9%) |
| Dec 2018 | $2.97 M(+149.9%) | $1.43 M(+35.0%) | $2.97 M(+92.1%) |
| Sept 2018 | - | $1.06 M(+312.5%) | $1.55 M(+214.6%) |
| June 2018 | - | $256.00 K(+8.5%) | $492.00 K(+108.5%) |
| Mar 2018 | - | $236.00 K | $236.00 K |
| Dec 2017 | $1.19 M | - | - |
FAQ
- What is Karuna Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Karuna Therapeutics?
- What is Karuna Therapeutics annual SG&A year-on-year change?
- What is Karuna Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Karuna Therapeutics?
- What is Karuna Therapeutics quarterly SG&A year-on-year change?
- What is Karuna Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Karuna Therapeutics?
- What is Karuna Therapeutics TTM SG&A year-on-year change?
What is Karuna Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of KRTX is $131.33 M
What is the all time high annual SG&A for Karuna Therapeutics?
Karuna Therapeutics all-time high annual selling, general & administrative expenses is $131.33 M
What is Karuna Therapeutics annual SG&A year-on-year change?
Over the past year, KRTX annual selling, general & administrative expenses has changed by +$55.26 M (+72.65%)
What is Karuna Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of KRTX is $47.39 M
What is the all time high quarterly SG&A for Karuna Therapeutics?
Karuna Therapeutics all-time high quarterly selling, general & administrative expenses is $47.39 M
What is Karuna Therapeutics quarterly SG&A year-on-year change?
Over the past year, KRTX quarterly selling, general & administrative expenses has changed by +$15.13 M (+46.89%)
What is Karuna Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of KRTX is -$3.31 B
What is the all time high TTM SG&A for Karuna Therapeutics?
Karuna Therapeutics all-time high TTM selling, general & administrative expenses is $131.33 M
What is Karuna Therapeutics TTM SG&A year-on-year change?
Over the past year, KRTX TTM selling, general & administrative expenses has changed by -$3.42 B (-3156.63%)